In patients with suspected acute coronary syndrome, implementing an early rule-out pathway, using an hs-cTnT concentration of <5 ng/L at presentation for risk stratification, reduced the duration of stay in hospital without compromising safety. This evidence concerns the gene TNNT2 and acute coronary syndrome.